BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4079228)

  • 1. [Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution].
    Liusov VA; Soboleva VN; Katyshkina NI
    Kardiologiia; 1985 Sep; 25(9):63-7. PubMed ID: 4079228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA; Diukov IV; Borodkin VV
    Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the hemorheological factors in ischemic heart disease and cerebrovascular disorders.
    Fukuda I; Yoshida T; Yoritsune H; Kiso T; Konishi S; Kawasaki T; Mozai T
    Bull Osaka Med Sch; 1978 Oct; 24(2):83-91. PubMed ID: 757138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isovolemic hemodilution in patients with coronary heart disease].
    Kiesewetter H; Erlenwein S; Jung F; Wenzel E; Vogel W; Dyckmans J; Bach R; Hahmann H; Schieffer H; Bette L
    Klin Wochenschr; 1988; 66 Suppl 15():8-14. PubMed ID: 3184787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostasis in ischemic heart disease patients undergoing hyperbaric oxygenation].
    Goliakov VN; Eroshina VA; Zimin IuV; Semiletova VI
    Klin Med (Mosk); 1986 Feb; 64(2):92-5. PubMed ID: 3702304
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of some haemocoagulatory and haemorheological variables to maximal exercise in sedentary and active subjects.
    De Scalzi M; Cinelli P; de Leonardis V; Becucci A; Mariani R; Fattirolli F; Ciapini A
    J Int Med Res; 1987; 15(6):361-7. PubMed ID: 3325319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure].
    Panchenko EP
    Kardiologiia; 1981 Aug; 21(8):50-5. PubMed ID: 7289383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the indicators of the blood coagulation and fibrinolysis systems in the pre-clinical stage of ischemic heart disease].
    Andreenko GV; Panchenko VM; Lisina AN; Liutova LV
    Kardiologiia; 1978 Oct; 18(10):57-60. PubMed ID: 713256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrocyte aggregation and fibrinogen derivatives in ischemic heart disease].
    Liusov VA; Parfenov AS; Belousov IuB; Rudakov AV; Nechaeva VN
    Kardiologiia; 1978 Jun; 18(6):42-8. PubMed ID: 672018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of emotional tension on intravascular coagulation in patients with angiographically established ischemic heart disease].
    Sokolov EI; Khovanskaia TP; Baluda MV; Novikova IV
    Kardiologiia; 1985 Feb; 25(2):34-8. PubMed ID: 3990077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart].
    Furkalo NK; Dukhina MA; Bol'shakova RM; SolovtsovA KM; Progonnaia
    Kardiologiia; 1976 Dec; 16(12):32-40. PubMed ID: 1011479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between disorders of the rheological properties of the blood and the system of hemostasis in patients with ischemic heart disease].
    Parfenov AS; Belousov IuB
    Kardiologiia; 1989 Oct; 29(10):47-50. PubMed ID: 2615158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isovolemic hemodilution in cerebral ischemic attack: clinical and hemorheological evaluation].
    Porro F; Curti L; Figini G; Pastori M
    Ric Clin Lab; 1989; 19 Suppl 1():113-6. PubMed ID: 2629068
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise].
    Kovalenko VM; Shunkova EI; Gol'dberg GA; Karagaeva LG; Shlafer ID; Epifantseva NN
    Kardiologiia; 1991 Sep; 31(9):42-4. PubMed ID: 1753613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isovolemic hemodilution in coronary heart disease--clinical and hemodynamic effects].
    Neubaur TE; Peters A; Schobel FC; Leschke M; Strauer BE
    Z Kardiol; 1996 Jan; 85(1):1-5. PubMed ID: 8717140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory signs of activation of the hemostasis system in patients with coronary heart disease, who had coronary artery bypass surgery.].
    Lisyutenko NS; Morova NA; Tsekhanovich VN
    Klin Lab Diagn; 2018; 63(8):500-505. PubMed ID: 30726655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.